Regulon

Regulon: R-1143

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
32-0.98298810Pr-134Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
5725 ENSG00000011304 PTBP1 A6NLN1
23517 ENSG00000039123 SKIV2L2 P42285
55718 ENSG00000058600 POLR3E Q9NVU0
55205 ENSG00000074657 ZNF532 Q9HCE3
9733 ENSG00000075856 SART3 Q15020
51729 ENSG00000084463 WBP11 Q9Y2W2
10523 ENSG00000085872 CHERP Q8IWX8
8898 ENSG00000087053 MTMR2 A0A6Q8PGT1
11198 ENSG00000092201 SUPT16H Q9Y5B9
10291 ENSG00000099995 SF3A1 Q15459
23394 ENSG00000101126 ADNP Q9H2P0
9777 ENSG00000101337 TM9SF4 Q92544
22850 ENSG00000101544 ADNP2 Q6IQ32
23347 ENSG00000101596 SMCHD1 A6NHR9
23361 ENSG00000102870 ZNF629 Q9UEG4
55756 ENSG00000104299 INTS9 Q9NV88
55188 ENSG00000111785 RIC8B A0A024RBG9
10657 ENSG00000121774 KHDRBS1 Q07666
3609 ENSG00000129351 ILF3 A0A024R7C7
10250 ENSG00000133226 SRRM1 Q8IYB3
5495 ENSG00000138032 PPM1B O75688
4841 ENSG00000147140 NONO Q15233
1105 ENSG00000153922 CHD1 O14646
23358 ENSG00000162402 USP24 Q9UPU5
26130 ENSG00000165219 GAPVD1 Q14C86
28511 ENSG00000168256 NKIRAS2 Q9NYR9
65110 ENSG00000169062 UPF3A Q9H1J1
5747 ENSG00000169398 PTK2 E5RH01
171023 ENSG00000171456 ASXL1 Q8IXJ9
10137 ENSG00000244462 RBM12 Q9NTZ6
55802 ENSG00000272886 DCP1A Q9NPI6
10236 ENSG00000282958 HNRNPR O43390

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
GSK-2256098PTK2Small moleculeINHIBITORFocal adhesion kinase 1 inhibitor20
BI-853520PTK2Small moleculeINHIBITORFocal adhesion kinase 1 inhibitor10
VS-4718PTK2Small moleculeINHIBITORFocal adhesion kinase 1 inhibitor10
DEFACTINIBPTK2BSmall moleculeINHIBITORFocal adhesion kinase 1 inhibitor20
CEP-37440ALKSmall moleculeINHIBITORFocal adhesion kinase 1 inhibitor10
CONTELTINIBPTK2Small moleculeINHIBITORProtein tyrosine kinase 2 beta inhibitor10

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1143

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs